Researchers compared the risks of aggressive breast cancers and mortality following DCIS undetected during screening in the general public to those identified through the NHS breast screening program.
MSD reports net income of $5.4bn in Q2 2024
MSD announced its full-year 2024 financial outlook, raising its expected worldwide sales range to between $63.4bn and $64.4bn. Credit: JHVEPhoto / Shutterstock. MSD has reported